Abbott Laboratories ABT NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score

80/100

5/7 Pass

SharesGrow Intrinsic Value

Abbott Laboratories (ABT) 报告总资产为 $86.71B 总负债为 $33.94B 財年 2025, 总权益为 $52.77B.

公司持有 $8.94B 现金及短期投资. 总债务为 $15.07B, 净债务为 $6.55B. D/E比率为 0.29 (保守的).

流动比率为 1.58, 表明短期流动性强. 利息覆蓋率为 23.6x (强劲的).

本页支持的标准:

HEALTH (100/100, Pass) — Debt-to-Equity of 0.29, current ratio of 1.58, interest coverage 23.6x — 资产负债表强劲
MOAT (86/100) — 总资产 $86.71B 和 equity $52.77B 支持公司的竞争规模
VALUE (58/100) — Debt-to-Equity 0.29 影响整体估值风险评估

SharesGrow 收入评分: 80/100 其中 5/7 项标准通过.

SharesGrow 7-Criteria Score

80/100

SG Score

View full scorecard →

价值

58/100

Price-to-Earnings & upside

→ Valuation

✓

未來

85/100

Analyst consensus

→ Forecast

✓

过去

100/100

→ Income

✓

健康

100/100

Debt-to-Equity & liquidity

Proven by this page

✓

护城河

86/100

→ Income

✓

成长

73/100

→ Income

收入

55/100

→ Income

Abbott Laboratories 资产负债表历史

指标	FY2025	FY2024	FY2023	FY2022
总资产	$86.71B	$81.41B	$73.21B	$74.44B
Total Liabilities	$33.94B	$33.51B	$34.39B	$37.53B
总债务	$15.07B	$15.02B	$15.87B	$17.72B
Cash & Investments	$8.94B	$7.97B	$7.28B	$10.17B
股东权益总计	$52.13B	$47.66B	$38.6B	$36.69B